Learn more about Wellumio
4 known investors
Wellumio develops Axana, a portable AI-enhanced magnetic resonance brain scanner designed to diagnose strokes at the point of care and accelerate treatment decisions during the critical first hour after stroke onset. The device targets emergency medicine settings and hospitals to reduce imaging bottlenecks and improve patient outcomes.